JANE STREET GROUP, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$666,590
-72.3%
41,558
-60.0%
0.00%
-100.0%
Q2 2023$2,408,194
+53.5%
103,891
+53.9%
0.00%0.0%
Q1 2023$1,568,466
+263.1%
67,519
+126.8%
0.00%
Q4 2022$432,021
+10.2%
29,774
+44.8%
0.00%
Q3 2022$392,000
-78.6%
20,567
-71.7%
0.00%
Q1 2022$1,832,000
+214.2%
72,714
+244.6%
0.00%
Q4 2021$583,000
-11.5%
21,102
+3.4%
0.00%
Q3 2021$659,000
-57.5%
20,400
-59.8%
0.00%
Q2 2021$1,550,000
+108.9%
50,700
+108.1%
0.00%
Q1 2021$742,000
-59.8%
24,366
-73.9%
0.00%
-100.0%
Q4 2020$1,847,000
+99.2%
93,384
+31.4%
0.00%
Q3 2020$927,000
+5.2%
71,054
-8.7%
0.00%
Q2 2020$881,000
-23.3%
77,795
+84.7%
0.00%
-100.0%
Q4 2019$1,148,000
+91.7%
42,129
+101.5%
0.00%
+100.0%
Q3 2019$599,000
+87.8%
20,910
+81.8%
0.00%0.0%
Q2 2019$319,000
+4.2%
11,500
+11.0%
0.00%0.0%
Q1 2018$306,000
-18.2%
10,364
-28.3%
0.00%0.0%
Q2 2017$374,000
+29.4%
14,458
+3.1%
0.00%0.0%
Q3 2016$289,000
-71.5%
14,029
-40.2%
0.00%
-83.3%
Q4 2015$1,013,000
+111.5%
23,461
+83.7%
0.01%
+100.0%
Q3 2015$479,000
+5.3%
12,770
-4.1%
0.00%
-40.0%
Q1 2014$455,00013,3180.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders